Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$729M |
| 2 |
Booking.com
BKNG
|
+$309M |
| 3 |
PepsiCo
PEP
|
+$294M |
| 4 |
Comcast
CMCSA
|
+$285M |
| 5 |
Netflix
NFLX
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$778M |
| 2 |
Walmart Inc
WMT
|
+$382M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
NetEase
NTES
|
+$344M |
| 5 |
Becton Dickinson
BDX
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.7% |
| 2 | Technology | 14.02% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.92% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FWDI
2626
Forward Industries Inc
FWDI
$297M
| $1.09M | ﹤0.01% |
77,110
+11,440
| +17% | +$201K |
|
2627
Barclays
BCS
$92.7B
| $1.09M | ﹤0.01% |
96,339
-1,128,835
| -92% | -$12.3M |
|
2628
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$473M
| $1.08M | ﹤0.01% |
+18,200
| New | +$1.07M |
|
2629
iShares Core S&P Small-Cap ETF
IJR
$109B
| $1.08M | ﹤0.01% |
+14,000
| New | +$1.09M |
|
2630
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
| $1.08M | ﹤0.01% |
17,700
-29,500
| -63% | -$1.81M |
|
2631
ClearOne Inc
CLRO
$10.9M
| $1.08M | ﹤0.01% |
9,020
-587
| -6% | -$71.6K |
|
|
IOTS
2632
DELISTED
Adesto Technologies Corp
IOTS
| $1.07M | ﹤0.01% |
145,000
-105,200
| -42% | -$713K |
|
2633
Enphase Energy
ENPH
$4.96B
| $1.07M | ﹤0.01% |
233,911
+108,511
| +87% | +$330K |
|
2634
CareDx
CDNA
$2.26B
| $1.06M | ﹤0.01% |
+133,300
| New | +$822K |
|
|
MRIN
2635
DELISTED
Marin Software
MRIN
| $1.06M | ﹤0.01% |
26,628
+1,233
| +5% | +$64.8K |
|
2636
Arcadia Biosciences
RKDA
$1.36M
| $1.06M | ﹤0.01% |
1,107
+416
| +60% | +$187K |
|
2637
Lantronix
LTRX
$240M
| $1.06M | ﹤0.01% |
515,166
+2,400
| +0.5% | +$5.33K |
|
|
SBBP
2638
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.06M | ﹤0.01% |
+119,600
| New | +$895K |
|
|
BHR
2639
Braemar Hotels & Resorts
BHR
$156M
| $1.05M | ﹤0.01% |
109,518
-197,354
| -64% | -$1.84M |
|
2640
Cal-Maine
CALM
$4.12B
| $1.05M | ﹤0.01% |
+24,100
| New | +$1.05M |
|
2641
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
| $1.05M | ﹤0.01% |
+26,300
| New | +$1.06M |
|
|
TCFC
2642
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $1.05M | ﹤0.01% |
28,300
+4,000
| +16% | +$149K |
|
2643
Sypris Solutions
SYPR
$42.8M
| $1.05M | ﹤0.01% |
645,200
-4,300
| -0.7% | -$6.35K |
|
|
SAND
2644
DELISTED
Sandstorm Gold
SAND
| $1.05M | ﹤0.01% |
+220,200
| New | +$1.07M |
|
|
CDTX
2645
DELISTED
Cidara Therapeutics
CDTX
| $1.05M | ﹤0.01% |
13,085
+4,120
| +46% | +$563K |
|
2646
Norwood Financial Corp
NWFL
$370M
| $1.04M | ﹤0.01% |
34,551
-2,299
| -6% | -$70.8K |
|
|
CAW
2647
DELISTED
CCA Industries, Inc.
CAW
| $1.03M | ﹤0.01% |
350,100
+1,000
| +0.3% | +$3.09K |
|
|
ATYR
2648
aTyr Pharma
ATYR
$47.6M
| $1.03M | ﹤0.01% |
27,721
+7,764
| +39% | +$364K |
|
2649
iShares MSCI Indonesia ETF
EIDO
$480M
| $1.03M | ﹤0.01% |
38,106
+13,800
| +57% | +$397K |
|
|
GNTY
2650
DELISTED
Guaranty Bancshares
GNTY
| $1.03M | ﹤0.01% |
33,880
+22,440
| +196% | +$665K |
|
Similar funds
Renaissance Technologies's Q1 2018 Portfolio in Review
As of Q1 2018, Renaissance Technologies held 3,782 positions worth $91.4B, up 0.81% from $90.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies's Q1 2018 filing shows 474 new, 1,646 increased, 1,191 reduced and 438 closed positions. Its largest new stake was Amazon: 10,199,100 shares worth $738M. The largest sale was ExxonMobil, an estimated $778M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2018 buy was Amazon: 10,199,100 shares worth $738M.
- Renaissance Technologies added most to Booking.com in Q1 2018, an estimated $309M increase.
- Renaissance Technologies's biggest Q1 2018 reduction was ExxonMobil, cutting an estimated $778M.
- Renaissance Technologies fully exited Marathon Petroleum in Q1 2018, selling an estimated $132M.
- Renaissance Technologies's ten largest holdings make up 9% of its $91.4B portfolio in Q1 2018.
- Renaissance Technologies opened 474 new positions and closed 438 in Q1 2018.
- Renaissance Technologies's portfolio value rose 0.81% quarter-over-quarter to $91.4B.
Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.